Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study
A.G. Venier(Université de Bordeaux), Rodolphe Thiébaut(Université de Bordeaux), Bernard Clair(Assistance Publique – Hôpitaux de Paris), Sylvie Parer(Centre Hospitalier Universitaire de Montpellier), D. Talon(Centre National de la Recherche Scientifique), Christine Lawrence(Assistance Publique – Hôpitaux de Paris), Christophe Leroyer, Bruno Mégarbane(Hôpital Avicenne), Alain Lepape(Hospices Civils de Lyon), C. Slekovec(Centre Hospitalier Universitaire de Besançon), D Trivier(Centre Hospitalier de Lens), Véronique Dubois(Centre National de la Recherche Scientifique), Pierre Cassier(Hôpital Edouard Herriot), S. Alfandari(Centre Hospitalier de Tourcoing), Xavier Bertrand(Centre National de la Recherche Scientifique), J.M. Guérin(Assistance Publique – Hôpitaux de Paris), M. Perraud(Hôpital Edouard Herriot), Julien Asselineau, A.-M. Rogues(Université de Bordeaux), Alexandre Boyer
Cited by 128
Related Papers
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
|Intensive Care Medicine|2021|421
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
|European Journal of Cardiovascular Prevention & Rehabilitation|2010|392